RankingsPricing
  1. US-listed companies
  2. Elevance Health, Inc.
  3. Financials
  4. Stock-based compensation

Elevance Health, Inc.ELV

Market cap
$81.1B
P/E ratio
SummaryFinancials
Period EndStock-based compensation (Million USD)YoY (%)
Dec 31, 2024191-27.65%
Dec 31, 2022264+3.53%
Dec 31, 2021255-9.89%
Dec 31, 2020283-3.74%
Dec 31, 2019294+30.09%
Dec 31, 2018226+33.25%
Dec 31, 2017170+3.04%
Dec 31, 2016165+11.07%
Dec 31, 2015148-12.26%
Dec 31, 2014169+15.68%
Dec 31, 2013146+8.31%
Dec 31, 2011135-0.88%
Dec 31, 2010136

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating income Operating expenses Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareAdjusted DPSEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)